Although NPAS3 was historically connected to neurogenesis, it has emerged as a predictive hallmark for triple-negative breast cancer as a tumour suppressor that drives the progression of breast cancer via the modulation of autophagy (Yu et al., 2024). Here, NPAS3 is linked to neoplasm.